Purchase Order 75N95C25P00085
Award Date
7/22/25
Potential Completion Date
7/21/26
Potential Value
$14K
Federal Agency
National Center for Advancing Translational Sciences
Awardee
Cellecta, Inc.
Ultimate Awardee
Not listed
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Mountain View, CA 94043, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $16,000.00 firm fixed price purchase order to Cellecta, Inc. for the delivery of a "HUMAN GENOME-WIDE CRISPRI DUAL-SGRNA LIBRARY (VIRUS)". This order, which does not have a set-aside designation, will be completed by September 7, 2022. Cellecta, Inc. is a for-profit organization that specializes in providing genetic screening services, including...
This is a $96,000 firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the National Institutes of Health (NIH), to Cellecta, Inc., a for-profit manufacturer of genetic research tools. The award supports NCATS' RNAi screening facility by enabling the development of flexible functional genomics platforms that offer complementary and orthogonal CRISPR screens to NIH intramural investigators. The contract does not...
This $24,000 firm fixed-price purchase order was awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), to Cellecta, Inc. Cellecta is a for-profit manufacturer of specialty genetic screening products and services used in medical research and drug discovery. The contract does not have a small business set-aside designation. Cellecta frequently partners as the prime contractor to provide CRISPR, RNAi, and other genomic...
This federal contract award to Cellecta, Inc., a for-profit manufacturer of genetic research tools, was issued by the National Institute on Drug Abuse (NIDA), a civilian agency within the National Institutes of Health (NIH). The $16,305 firm fixed-price purchase order is for the delivery of a pooled single guide RNA (sgRNA) CRISPR-Cas9 library, which will support biomedical research initiatives. The contract did not have a small business set-aside designation. Cellecta has been a consistent...
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $20,130.00 firm-fixed-price purchase order to Cellecta, Inc. (doing business as Cellecta Inc.), a for-profit organization and manufacturer of goods. The award is for the delivery of a human genome-wide CRISPR-Cas9 dual-single guide RNA (sgRNA) library (virus). This contract is not set aside for any type of small business. Cellecta has previously provided a...
This contract was awarded by the Department of Health and Human Services National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) to Synthego Corporation, a self-certified small disadvantaged business, for the provision of a Custom sgRNA CRISPR Library. The contract has a potential value of $25,175.00 and is a firm fixed-price purchase order with a 12-week period of performance. The Custom sgRNA CRISPR Library is being procured to support NCATS'...
This is a $60,132.50 firm-fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the National Institutes of Health (NIH), to Synthego Corporation, a self-certified small disadvantaged business and manufacturer of gene editing products. The contract is for the provision of a Whole Human Genome Arrayed CRISPR Screening Library to support NCATS' translational science research efforts. This award is not associated with a...
This is a $88,310 firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Synthego Corporation, a small disadvantaged business manufacturer of gene editing products. The contract is for CRISPR gene editing services to develop five different induced pluripotent stem (iPS) cell lines expressing fluorescent proteins or HiBiT tags at specific target genes. This is a non-competitive award under...
This federal contract was awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Cellecta, Inc., a for-profit manufacturer of genomic research products and services. The $299,952 firm-fixed price contract is for "GENETIC ANALYSIS OF CTCS AT THE SINGLE-CELL LEVEL" and does not have a set-aside designation. Cellecta specializes in providing advanced genomic technologies, including CRISPR, RNAi, and other tools, to support biomedical research...
Cellecta, Inc., doing business as Cellecta Inc., has been awarded a $10,410 firm fixed-price purchase order by the National Institutes of Health's National Center for Advancing Translational Sciences to provide unspecified products or services from July 12, 2023 through September 10, 2023. As the prime contractor, Cellecta will perform all work under the award, which was issued using full and open competition procedures with no set-aside designation. The Department of Health and Human Services...